Examining Pre-Pregnancy Health and Maternal Outcomes among Women Veterans
Examining Pre-Pregnancy Health and Maternal Outcomes among Women Veterans
批准号:
10314239
负责人:
Deirdre A Quinn
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-08-31
关键词:
AcuteAgeAreaAttitudeBirthCaringCessation of lifeChronicClinicalColorDataDevelopmentEclampsiaEthnic OriginEtiologyEventFeedbackFoundationsFutureGoalsHealthHealth ServicesHealth Services AccessibilityHealthcareHeart failureHigh PrevalenceIncidenceInterventionInterviewKnowledgeLeadershipLinkLiteratureLow incomeMaternal HealthMaternal MortalityMedicalMental HealthMentorshipMethodologyNot Hispanic or LatinoOutcomePatientsPatternPilot ProjectsPoliciesPopulationPovertyPregnancyPregnancy ComplicationsPregnancy RatePrevalencePreventionPrimary Health CareProviderQualitative ResearchRaceReproductive HealthResearchResearch MethodologyResearch PersonnelResearch PriorityRiskRisk FactorsRoleSamplingSepsisSiteSocial CharacteristicsStrategic PlanningStrokeStructureSubgroupTelephoneTestingTimeTrainingUnited StatesVariantVeteransWomanWomen&aposs HealthWomen&aposs Health ServicesWorkacceptability and feasibilityadverse maternal outcomesbaseblack womencare coordinationcareerchild bearingcohortcomorbiditydesigneffective interventionethnic minority populationexperiencefeasibility testingfollow-uphealth care deliveryhealth care servicehealth equityhigh riskimprovedinformantinnovationmaternal morbiditymaternal outcomemulti-component interventionoperationpatient orientedpreferencepregnancy associated deathpregnancy healthpregnancy related deathpregnantprepregnancyprogramsracial discriminationracial minorityrecruitreproductive outcomerural arearural residenceruralitysevere maternal morbiditysocialtherapy designtherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background. In the United States, two women die every day from pregnancy-related complications. Non-
Hispanic Black women die at 3 to 4 times the rate of non-Hispanic White women, and women living in rural
areas and women with low income are also at increased risk. For every pregnancy-related death, about 100
more women nearly die due to severe maternal morbidity (SMM), or complications from pregnancy and/or
delivery that result in significant lasting health consequences. Research suggests that >60% of these deaths
and SMM events are preventable, and that improving women’s health before pregnancy (e.g., managing
chronic medical and mental health conditions) may be one key to prevention. Little is known about women
Veterans’ pre-pregnancy health risks and maternal outcomes. Preliminary data from pilot work suggest that the
rate of pregnancy-associated deaths among Veterans using VA maternity care benefits is nearly double the
national rate. Because women Veterans have a high prevalence of chronic medical and mental health
conditions, and given that half (48%) of women Veterans age 18-45 identify as non-White and 25% live in rural
areas, it is critical to examine the role of these pre-pregnancy health risks in adverse maternal outcomes and to
explore how patterns of comorbid health risk factors vary among women from vulnerable subgroups.
Significance / Impact. The proposed research will fill major gaps in the literature about the etiology of
maternal mortality and SMM both within and outside of VA, and directly aligns with VHA and HSR&D priorities
around women’s health and health equity. Innovation. This study is the first to examine the impact of pre-
pregnancy health risks on maternal outcomes among a national cohort of women Veterans and the first to
examine whether social characteristics modify associations between pre-pregnancy health and maternal
outcomes. Specific Aims. Aim 1 is a quantitative study to classify women Veterans according to co-occurring
pre-pregnancy health risks, describe associations between risk profile groups and adverse maternal outcomes,
and identify how these associations vary across population subgroups. Aim 2 is a qualitative study to examine
women Veterans’ pre-pregnancy healthcare needs, experiences, and preferences. Aim 3 involves intervention
development, refinement, and pilot testing with the input of key VA clinical and operational informants and
women Veterans. Methodology. Aim 1 will use latent class analysis and multiple regression to examine a
national cohort of over 30,000 pregnancies to women Veterans in FY2010-2019. Aim 2 will recruit and
interview ~30 women Veterans about their experiences and needs related to pre-pregnancy health and health
care in VA. Aim 3 will recruit ~6 VA clinical and operational informants and ~3 women Veterans for a VA
stakeholder advisory panel, 5-10 women Veterans and their providers to provide feedback on intervention
components, and 10-15 women Veterans and providers to pilot test the intervention components.
Implementation / Next Steps. Findings will be presented to local and national operations partners and will
directly inform follow-up research to test one or more of a set of patient-centered pre-pregnancy health
intervention strategies in multiple VA primary care sites. Candidate. Dr. Deirdre Quinn is a postdoctoral
research fellow in women’s health at the VA Center for Health Equity Research and Promotion. The purpose of
this CDA-2 is to facilitate Dr. Quinn’s successful transition to an independent VA health services investigator
focused on achieving quality and equity in women Veterans’ reproductive health. The objective of this CDA-2
research is to examine how links between women Veterans’ pre-pregnancy health risks (e.g., chronic
conditions), social characteristics (e.g., race/ethnicity, rurality), healthcare experiences, and maternal
outcomes can inform opportunities to improve women Veterans’ healthcare. This objective will be achieved
through expert mentorship and in-depth training in: (1) advanced quantitative research; (2) qualitative research;
(3) designing and testing intervention strategies to improve women’s health; and (4) professional leadership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Examining Pre-Pregnancy Health and Maternal Outcomes among Women Veterans
-
批准号:10478948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Deirdre A Quinn
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: